Non-Hodgkin lymphoma

Risk factors for damaged liver function after chemotherapy in hepatitis B virus carriers with non-Hodgkin lymphoma

X. Li, Fan, X. W., Liu, W., Guo, L., Li, Y., Hu, X., Liang, X., Ma, X. P., and Yang, S. E., Risk factors for damaged liver function after chemotherapy in hepatitis B virus carriers with non-Hodgkin lymphoma, vol. 14, pp. 2647-2653, 2015.

The goal of this study was to investigate damaged liver function after chemotherapy in hepatitis B virus (HBV) carriers with non-Hodgkin lymphoma (NHL) and to evaluate risk factors associated with a high risk of damaged liver function. Clinical histories of 134 HBV carriers with NHL who were treated with chemotherapy were obtained and analyzed for the occurrence of damaged liver function and other related high-risk factors.

Subscribe to Non-Hodgkin lymphoma